These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 31956965)

  • 1. Nanotechnology in the arena of cancer immunotherapy.
    Asadujjaman M; Cho KH; Jang DJ; Kim JE; Jee JP
    Arch Pharm Res; 2020 Jan; 43(1):58-79. PubMed ID: 31956965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanotechnology platforms for cancer immunotherapy.
    Yang Z; Ma Y; Zhao H; Yuan Y; Kim BYS
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Mar; 12(2):e1590. PubMed ID: 31696664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent Advances in Cell Membrane-Derived Biomimetic Nanotechnology for Cancer Immunotherapy.
    Raza F; Zafar H; Zhang S; Kamal Z; Su J; Yuan WE; Mingfeng Q
    Adv Healthc Mater; 2021 Mar; 10(6):e2002081. PubMed ID: 33586322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced nanotechnology: An arsenal to enhance immunotherapy in fighting cancer.
    Cheng CT; Castro G; Liu CH; Lau P
    Clin Chim Acta; 2019 May; 492():12-19. PubMed ID: 30711524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanoparticle-Based Nanomedicines to Promote Cancer Immunotherapy: Recent Advances and Future Directions.
    Liu J; Zhang R; Xu ZP
    Small; 2019 Aug; 15(32):e1900262. PubMed ID: 30908864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanoparticle-based immunoengineering strategies for enhancing cancer immunotherapy.
    Dang BN; Kwon TK; Lee S; Jeong JH; Yook S
    J Control Release; 2024 Jan; 365():773-800. PubMed ID: 38081328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in engineering local drug delivery systems for cancer immunotherapy.
    Abdou P; Wang Z; Chen Q; Chan A; Zhou DR; Gunadhi V; Gu Z
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Sep; 12(5):e1632. PubMed ID: 32255276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted Nanoparticle Drug Delivery System for the Enhancement of Cancer Immunotherapy.
    Zhang H; Wu Y; Hu Y; Li X; Zhao M; Lv Z
    J Biomed Nanotechnol; 2019 Sep; 15(9):1839-1866. PubMed ID: 31387674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoparticle-based strategies for cancer immunotherapy and immunodiagnostics.
    Grimaldi AM; Incoronato M; Salvatore M; Soricelli A
    Nanomedicine (Lond); 2017 Oct; 12(19):2349-2365. PubMed ID: 28868980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer nanoimmunotherapy using advanced pharmaceutical nanotechnology.
    Li W; Wei H; Li H; Gao J; Feng SS; Guo Y
    Nanomedicine (Lond); 2014 Nov; 9(16):2587-605. PubMed ID: 25490427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nano-Enhanced Cancer Immunotherapy: Immunology Encounters Nanotechnology.
    Bockamp E; Rosigkeit S; Siegl D; Schuppan D
    Cells; 2020 Sep; 9(9):. PubMed ID: 32942725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving cancer immunotherapy through nanotechnology.
    Goldberg MS
    Nat Rev Cancer; 2019 Oct; 19(10):587-602. PubMed ID: 31492927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances of functional nanomaterials for cancer immunotherapeutic applications.
    Hao Y; Zhou X; Li R; Song Z; Min Y
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Mar; 12(2):e1574. PubMed ID: 31566896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineering nanoparticle strategies for effective cancer immunotherapy.
    Yoon HY; Selvan ST; Yang Y; Kim MJ; Yi DK; Kwon IC; Kim K
    Biomaterials; 2018 Sep; 178():597-607. PubMed ID: 29576282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Development of a Nano DDS for Cancer Immunotherapy Based on Llipid Nanoparticles].
    Nakamura T
    Yakugaku Zasshi; 2018; 138(12):1443-1449. PubMed ID: 30504656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gold nanoparticle mediated cancer immunotherapy.
    Almeida JP; Figueroa ER; Drezek RA
    Nanomedicine; 2014 Apr; 10(3):503-14. PubMed ID: 24103304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancing Combined Immunotherapy and Radiotherapy through Nanomedicine.
    Hagan CT; Mi Y; Knape NM; Wang AZ
    Bioconjug Chem; 2020 Dec; 31(12):2668-2678. PubMed ID: 33251789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanotechnology Approaches to Improving Cancer Immunotherapy.
    Hagan CT; Medik YB; Wang AZ
    Adv Cancer Res; 2018; 139():35-56. PubMed ID: 29941106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineering nanoparticles to reprogram radiotherapy and immunotherapy: recent advances and future challenges.
    Jin J; Zhao Q
    J Nanobiotechnology; 2020 May; 18(1):75. PubMed ID: 32408880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advancements in nanomedicine delivery systems: unraveling immune regulation strategies for tumor immunotherapy.
    Zhang Y; Chen X; Hu B; Zou B; Xu Y
    Nanomedicine (Lond); 2024; 19(21-22):1821-1840. PubMed ID: 39011582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.